Brukinsa Den Europæiske Union - slovakisk - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastické činidlá - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Sotyktu Den Europæiske Union - slovakisk - EMA (European Medicines Agency)

sotyktu

bristol-myers squibb pharma eeig - deucravacitinib - svrab - imunosupresíva - treatment of moderate-to-severe plaque psoriasis in adults.

Opdualag Den Europæiske Union - slovakisk - EMA (European Medicines Agency)

opdualag

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanóm - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

Taxier 100 mg Slovakiet - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

taxier 100 mg

zentiva a.s., slovensko - sildenafil - 83 - vasodilatantia

Taxier 50 mg Slovakiet - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

taxier 50 mg

zentiva a.s., slovensko - sildenafil - 83 - vasodilatantia